Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer

Gynecologic Oncology

Volumn 92, Issue 1, 2004, Pages 59-63

  Park, Dong Choon ^a   Kim, Jae Hoon ^a   Lew, Young Ok ^a   Kim, Dae Hoon ^a   Namkoong, Sung Eun ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Cisplatin; Neoadjuvnant chemotherapy; Paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PACLITAXEL;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ALLERGIC REACTION; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG ADMINISTRATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; GYNECOLOGICAL EXAMINATION; HAIR LOSS; HEART ARRHYTHMIA; HEMATURIA; HUMAN; HUMAN TISSUE; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LUNG TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PATHOLOGY; PATIENT ATTITUDE; PERICARDITIS; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEINURIA; PUNCH BIOPSY; SIDE EFFECT; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURGICAL RISK; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX TUMOR; WORLD HEALTH ORGANIZATION;

EID: 0742289998     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.09.015     Document Type: Article

References (17)

1. Kuehnle H., Meerpohl H.G., Eiermann W., Achterrath W. Neoadjuvant therapy for cervical cancer. Semin. Oncol. 19:1992;94-98.
2. Thomas G.M. Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. N. Engl. J. Med. 340:1999;1198-1200.
3. Sardi J., Sananes C., Giaroli A., Bayo J., Rueda N.G., Vighi S.et al. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol. Oncol. 49(2):1993;156-165.
4. Serur E., Mathews R.P., Gates J., Levine P., Maiman M., Remy J.C. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Gynecol. Oncol. 65(2):1997;348-356.
5. Lahousen M., Pickel H., Haas J. Adjuvant chemotherapy after radical hysterectomy for cervical cancer. Bailliere's Clin. Obstet. Gynaecol. 2(4):1998;1049-1057.
6. Grigsby P.W. Cervical cancer: combined modality therapy. Cancer. 1:2001;S47-S50.
7. Giardina G., Richiardi G., Danese S., Ottone P., Ohlmeier U., Gargiulo T. Weekly cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer: a well tolerate alternative. Eur. J. Gynaecol. Oncol. 18:1997;173-176.
8. Thigpen T., Vance R., Khansur T., Malamud F. The role of paclitaxel in the management of patients with carcinoma of the cervix. Semin. Oncol. 24(Suppl. 2):1997;S2-41-S2-46.
9. Rowinsky E.K., Gilbert M.R., McGuire W.P., Noe D.A., Grochow L.B., Forastiere A.A.et al. Sequences of Taxol and cisplatin: a phase I and pharmacologic study. J. Clin. Oncol. 9:1991;1692-1703.
10. Sardi J.E., di Paola G.R., Giaroli A., Sananes C., Gomez Rueda N., Cachau A.et al. Results of a phase II trial with neoadjuvant chemotherapy in carcinoma of the cervix uteri. Gynecol. Oncol. 31(2):1988;256-261.
11. Bloss J.D., Lucci J.A. III, DiSaia P.J., Manetta A., Schiano M.A., Ramsinghani N.et al. A phase II trial of neoadjuvant chemotherapy prior to radical hysterectomy and/or radiation therapy in the management of advanced carcinoma of the uterine cervix. Gynecol. Oncol. 59(1):1995;105-110.
12. Leone B., Vallejo C., Perez J., Cuevas M.A., Machiavelli M., Lacava J.et al. Ifosamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma. Am. J. Clin. Oncol. 19(2):1996;132-135.
13. Vallejo C.T., Perez J.E., Dominguez M.E., Leone B.A., Machiavelli M.R., Lacava J.A.et al. Neoadjuvant chemotherapy with ifosfamide, cisplatin, and vinorelbine in advanced squamous cell carcinoma of the cervix. Am. J. Clin. Oncol. 23(5):2000;481-486.
14. Serur E., Mathews R.P., Gates J.et al. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Gynecol. Oncol. 65:1997;348-356.
15. Namkoong W.D., Park J.S., Kim J.W.et al. Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without perioperative adjuvant chemotherapy. Gynecol. Oncol. 59:1995;136-142.
16. Piver M.S., Ghamande S.A., Eltabbakh G.H., O'Neill-Coppola C. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix - A phase II study. Gynecol. Oncol. 75(3):1999;334-337.
17. Papadimitriou C.A., Sarris K., Moulopoulos L.A., Fountzilas G., Anagnostopoulos A.et al. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J. Clin. Oncol. 17(3):1999;761-766.